Detalhe da pesquisa
1.
[177Lu]Lu-DOTA-TATE versus standard of care in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs): a cost-consequence analysis from an Italian hospital perspective.
Eur J Nucl Med Mol Imaging
; 49(6): 2037-2048, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34950969
2.
Use of [177Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study.
EJC Suppl
; 16: 14-23, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34912479
3.
Real-world comparison of healthcare resource utilization and costs of [177Lu]Lu-DOTA-TATE in patients with progressive neuroendocrine tumors in England: a matched cohort analysis using data from the hospital episode statistics dataset.
Curr Med Res Opin
; 38(8): 1305-1317, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35418254
4.
Peptide receptor radiotherapy re-treatment in patients with progressive neuroendocrine tumors: A systematic review and meta-analysis.
Cancer Treat Rev
; 93: 102141, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33418096
5.
Estimation of Health-Related Utilities for 177Lu-DOTATATE in GEP-NET Patients Using Utilities Mapped from EORTC QLQ-C30 to EQ-5D-3L and QLU-C10D Utilities.
Pharmacoecon Open
; 5(4): 715-725, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34260017
6.
Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE.
J Nucl Med
; 2021 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33771903
7.
Cost-effectiveness of lutetium (177Lu) oxodotreotide vs everolimus in gastroenteropancreatic neuroendocrine tumors in Norway and Sweden.
World J Clin Cases
; 8(20): 4793-4806, 2020 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-33195647
8.
Quality of life in patients with gastroenteropancreatic tumours: A systematic literature review.
World J Gastroenterol
; 26(25): 3686-3711, 2020 Jul 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32742136
9.
The Costs of Implementing Vaccination With the RTS,S Malaria Vaccine in Five Sub-Saharan African Countries.
MDM Policy Pract
; 4(2): 2381468319896280, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31903424
10.
Adjunctive psychosocial therapies for the treatment of schizophrenia.
Schizophr Res
; 100(1-3): 108-19, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18226500
11.
Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea.
Hum Vaccin Immunother
; 14(1): 85-94, 2018 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29115905
12.
Physician observations and perceptions of positive and negative symptoms of schizophrenia: a multinational, cross-sectional survey.
Eur Psychiatry
; 22(6): 371-9, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17521890
13.
Corrigendum to "Peptide receptor radiotherapy re-treatment in patients with progressive neuroendocrine tumors: A systematic review and meta-analysis" [Cancer Treatm. Rev. 93 (2021) 102141].
Cancer Treat Rev
; 97: 102203, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33857824
14.
Cost-effectiveness analysis of routine pneumococcal vaccination in the UK: a comparison of the PHiD-CV vaccine and the PCV-13 vaccine using a Markov model.
BMJ Open
; 6(11): e010776, 2016 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-27903558
15.
Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial.
Ann Intern Med
; 140(11): 867-73, 2004 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15172900
16.
Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children.
Infect Dis Ther
; 2014 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25527448
17.
Reply to Farkouh RA et al. Comment on "Cost-Effectiveness Evaluation of the 10-Valent Pneumococcal Non-Typeable Haemophilus Influenzae Protein D Conjugate Vaccine and 13-Valent Pneumococcal Vaccine in Japanese Children".
Infect Dis Ther
; 4(2): 235-44, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25908482